Current availability: qualification conversations for a bounded research-stage evaluation. Any evaluation requires written scope, site approval, local evidence review, and applicable legal, privacy, security, governance, and regulatory review.·© 2025-2026 VitaSignal LLC. All rights reserved.
    Technology Licensing

    VitaSignal
    Technology Licensing

    VitaSignal reviews qualified licensing inquiries from EHR vendors, health systems, and research institutions for its research-stage clinical AI components. Licensing does not convey clinical clearance, validated performance, or production readiness.

    Looking to run a pilot instead of licensing the technology. Request a Readiness Evaluation Scoping Conversation on the readiness review page.

    Intellectual-property disclosure

    VitaSignal methods, software, written materials, and unpublished research content are proprietary and protected under applicable intellectual-property and trade-secret law. Specific intellectual-property details are not published and are discussed only under a written agreement.

    Evidence maturity

    Evidence maturity differs by component. Evaluations used de-identified retrospective critical-care data where available, including fixed first-day windows. Intended-use, workflow, fairness-benefit, and clinical-utility endpoints remain reserved for prospective validation. Negative, mixed, and not-run findings are preserved. Component identities and method details are not published.

    Any license, research access, or disclosure would be defined by a written agreement after scope, ownership, status, confidentiality, and use limitations are confirmed. This page does not guarantee access to any particular component, documentation set, evaluation result, intellectual-property right, clinical clearance, validated performance, or production capability.

    Licensing Paths

    Qualified inquiries by organization type

    Every path below begins with a mutual NDA. Terms, scope, and fees are documented in a written agreement specific to your organization and use case.

    EHR vendors and health systems

    Component licensing

    Access to a specific research-stage lane under NDA, scoped in a written agreement

    Terms and fees are negotiated per engagement. No standardized public pricing is available for licensing.

    Email licensing@vitasignal.ai
    Academic

    Research access

    Academic and research institution access to component-specific research materials

    MTA or DUA required. IRB support available for qualifying collaborations.

    Email licensing@vitasignal.ai
    Prefer to reach us through the general contact form instead. Visit the Contact page and select Technology Licensing.

    Inquiry Form

    Submit a Licensing Inquiry

    Complete the form below and our licensing team will respond within 2 business days.

    VitaSignal methods, software, written materials, and unpublished research content are proprietary and protected under applicable intellectual-property and trade-secret law. Specific intellectual-property details are not published and are discussed only under a written agreement. All licensing discussions are conducted under mutual NDA. Any license, research access, or disclosure would be defined by a written agreement after scope, ownership, status, confidentiality, and use limitations are confirmed. © 2026 VitaSignal LLC. All rights reserved.